Clinical trial
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for…
NCT00002742 · Aronex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00002742 |
|---|---|
| Title | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer |
| Official title | A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, COMPARATIVE, MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF NYSTATIN AND AMPHOTERICIN B FOR EMPIRIC ANTIFUNGAL TREATMENT IN NEUTROPENIC PATIENTS |
| Lead sponsor | Aronex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | amphotericin B deoxycholate, nystatin |
| Start date | Jan 1, 1996 |
| Completion | Sep 1, 2007 |
| First posted | Aug 24, 2004 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: